Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when WHWK files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsWhitehawk Therapeutics shareholders approve director slate, executive pay at annual meeting
Filed June 12, 2026 · Period ending June 11, 2026 · ~1 min read
Key Changes
-
low
Shareholders elected three Class III directors (Behzad Aghazadeh, Richard Maroun, Emma Reeve) to serve three-year terms through 2029, with 82% of voting shares represented at the meeting.
Item 5.07 verify on EDGAR → -
low
Executive compensation received advisory approval from shareholders in non-binding say-on-pay vote.
Item 5.07 verify on EDGAR → -
low
BDO USA ratified as independent auditor for fiscal year 2026.
Item 5.07 verify on EDGAR →
Summary
Whitehawk Therapeutics held its 2026 annual stockholder meeting on June 11, with strong participation representing 82% of voting shares. Shareholders approved all three proposals on the ballot: electing the board's nominated slate of three Class III directors to three-year terms, providing advisory approval of executive compensation, and ratifying the company's auditor choice. This is a routine governance filing with no material business developments.
The strong quorum and passage of all proposals suggests shareholder alignment with management. Retail investors should watch for the company's upcoming proxy statement details on executive compensation levels and any director independence considerations, though this 8-K itself contains no actionable information requiring immediate attention.
Section-by-Section Diff
Event · Item 5.07 — Submission of Matters to a Vote of Security Holders
Whitehawk Therapeutics held its 2026 annual meeting, electing three directors, approving executive compensation, and ratifying BDO USA as auditor.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
At the Annual Meeting, 40,375,023 shares of common stock of the Company, representing approximately 82% of the voting power of all issued and outstanding shares of common stock of the Company as of April 17, 2026, the record date for the Annual Meeting, and constituting a quorum for the transaction of business, were present in person or by proxy
The company held its annual stockholder meeting on June 11, 2026, with 82% of voting shares represented. Stockholders voted on three proposals: electing three Class III directors (Behzad Aghazadeh, Richard Maroun, and Emma Reeve) to serve until 2029, approving executive compensation on an advisory basis, and ratifying BDO USA as the independent auditor for fiscal 2026. All three proposals passed with majority support.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 14, 2026 · How we verify